THE ALDOSE REDUCTASE CONTROVERSY

[1] BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315

[2] ALDOSE REDUCTASE INHIBITION FAILS TO PREVENT RETINOPATHY IN DIABETIC AND GALACTOSEMIC DOGS [J]. DIABETES, 1993, 42 (06) : 820 - 825

[3] EXPERIMENTAL GALACTOSEMIA PRODUCES DIABETIC-LIKE RETINOPATHY [J]. DIABETES, 1984, 33 (01) : 97 - 100

[4] NERVE-CONDUCTION VELOCITY IN DOGS IS REDUCED BY DIABETES AND NOT BY GALACTOSEMIA [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (06): : 638 - 640

[5] ENGERMAN RL, 1992, DIABETOLOGIA, V35, pA45

[6] FAGIUS J, 1985, DIABETOLOGIA, V28, P323

[7] ALDOSE REDUCTASE INHIBITION - THE CHEMICAL KEY TO THE CONTROL OF DIABETIC-RETINOPATHY [J]. ARCHIVES OF OPHTHALMOLOGY, 1990, 108 (09) : 1229 - 1231

[8] FRANK RN, 1983, INVEST OPHTH VIS SCI, V24, P1519

[9] NERVE-CONDUCTION DEFECT IN GALACTOSE-FED RATS [J]. DIABETES, 1972, 21 (05) : 295 - &

[10] SORBITOL PATHWAY - PRESENCE IN NERVE AND CORD WITH SUBSTRATE ACCUMULATION IN DIABETES [J]. SCIENCE, 1966, 151 (3707) : 209 - &

[1] BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315

[2] ALDOSE REDUCTASE INHIBITION FAILS TO PREVENT RETINOPATHY IN DIABETIC AND GALACTOSEMIC DOGS [J]. DIABETES, 1993, 42 (06) : 820 - 825

[3] EXPERIMENTAL GALACTOSEMIA PRODUCES DIABETIC-LIKE RETINOPATHY [J]. DIABETES, 1984, 33 (01) : 97 - 100

[4] NERVE-CONDUCTION VELOCITY IN DOGS IS REDUCED BY DIABETES AND NOT BY GALACTOSEMIA [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (06): : 638 - 640

[5] ENGERMAN RL, 1992, DIABETOLOGIA, V35, pA45

[6] FAGIUS J, 1985, DIABETOLOGIA, V28, P323

[7] ALDOSE REDUCTASE INHIBITION - THE CHEMICAL KEY TO THE CONTROL OF DIABETIC-RETINOPATHY [J]. ARCHIVES OF OPHTHALMOLOGY, 1990, 108 (09) : 1229 - 1231

[8] FRANK RN, 1983, INVEST OPHTH VIS SCI, V24, P1519

[9] NERVE-CONDUCTION DEFECT IN GALACTOSE-FED RATS [J]. DIABETES, 1972, 21 (05) : 295 - &

[10] SORBITOL PATHWAY - PRESENCE IN NERVE AND CORD WITH SUBSTRATE ACCUMULATION IN DIABETES [J]. SCIENCE, 1966, 151 (3707) : 209 - &